drugset / Trial / NCT04318444
Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19)
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to test the hypothesis that post-exposure prophylaxis with hydroxychloroquine will reduce the symptomatic secondary attack rate among household contacts of known or suspected COVID-19 patients.
Timeline
- Start
- 2020-03-29
- Primary completion
- 2021-03-31
- Completion
- 2021-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydroxychloroquine | Small molecule | 200 mg | — |